Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $10.12 trillion, total revenue of $4.71 trillion and a weighted average PE ratio of 49.13.
Market Cap
10.12T
Revenue
4.71T
Profits
205.9B
PE Ratio
49.13
Profit Margin
4.38%
Dividend Yield
0.37%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.27T | 1.52% | 1,468,290 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 658.64B | 2.79% | 4,021,382 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 512.08B | 1.32% | 2,917,930 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.83B | 0.77% | 4,915,891 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 365.56B | 2.42% | 2,770,235 | 67.38B |
| 6 | NVS | Novartis AG | 312.86B | 3.38% | 908,933 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 294.95B | 3.00% | 1,970,114 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 260.34B | 0.62% | 1,056,435 | 47.35B |
| 9 | AMGN | Amgen Inc. | 258.21B | 3.54% | 1,858,499 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 215.32B | 3.66% | 3,427,893 | 30.99B |
| 11 | ABT | Abbott Laboratories | 198.86B | 5.05% | 4,804,825 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 190.95B | 6.92% | 15,174,681 | 50.70B |
| 13 | PFE | Pfizer Inc. | 173.84B | 1.67% | 21,292,725 | 63.63B |
| 14 | ISRG | Intuitive Surgical, Inc. | 167.21B | 9.44% | 2,361,602 | 11.58B |
| 15 | DHR | Danaher Corporation | 164.04B | 1.33% | 1,166,121 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.29B | 2.80% | 570,097 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.04B | 2.30% | 3,422,799 | 50.03B |
| 18 | MDT | Medtronic plc | 128.74B | 6.36% | 5,371,418 | 37.54B |
| 19 | SYK | Stryker Corporation | 127.58B | 7.91% | 1,799,275 | 26.30B |
| 20 | MCK | McKesson Corporation | 119.58B | 2.60% | 212,457 | 410.98B |
| 21 | SNY | Sanofi | 113.17B | 4.21% | 2,584,754 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 106.59B | 10.24% | 1,576,001 | 78.70B |
| 23 | GSK | GSK plc | 103.08B | 4.87% | 3,052,360 | 44.53B |
| 24 | CVS | CVS Health Corporation | 102.66B | -12.19% | 18,752,602 | 418.38B |
| 25 | MRNA | Moderna, Inc. | 98.84B | 8.37% | 7,452,595 | 2.23B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 95.33B | -2.40% | 526,639 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 92.65B | 3.65% | 529,601 | 201.83B |
| 28 | CI | The Cigna Group | 80.31B | 2.87% | 766,854 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.00B | 0.89% | 1,535,983 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.53B | 2.38% | 1,027,946 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 66.49B | 5.47% | 15,084,724 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 59.66B | 1.86% | 573,060 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 57.50B | 4.80% | 2,593,011 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 56.67B | 4.98% | 810,342 | 22.48B |
| 35 | ARGX | argenx SE | 56.19B | 1.77% | 364,089 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.27B | 4.40% | 475,192 | 4.66B |
| 37 | NTRA | Natera, Inc. | 54.63B | -2.48% | 1,186,611 | 2.71B |
| 38 | MDLN | Medline Inc. | 51.18B | 14.20% | 9,056,670 | 30.68B |
| 39 | HUM | Humana Inc. | 50.14B | -0.08% | 786,446 | 145.68B |
| 40 | A | Agilent Technologies, Inc. | 50.05B | 1.18% | 574,413 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 49.73B | 1.29% | 527,959 | 3.46B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 49.48B | 1.31% | 3,740,631 | 17.23B |
| 43 | WAT | Waters Corporation | 45.93B | 1.66% | 370,168 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 43.58B | 0.72% | 374,050 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 42.58B | 5.48% | 334,946 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.01B | 0.91% | 844,434 | - |
| 47 | HLN | Haleon plc | 40.03B | 4.02% | 17,111,718 | 14.80B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 39.23B | 7.58% | 4,368,975 | 21.64B |
| 49 | RPRX | Royalty Pharma plc | 38.02B | -0.41% | 1,038,634 | 2.62B |
| 50 | ALC | Alcon Inc. | 37.78B | 7.19% | 1,757,874 | 10.86B |
| 51 | BIIB | Biogen Inc. | 37.12B | 0.87% | 390,172 | 10.30B |
| 52 | CNC | Centene Corporation | 36.25B | 8.51% | 4,469,120 | 180.41B |
| 53 | ZTS | Zoetis Inc. | 36.04B | 5.10% | 2,989,071 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.65B | 1.83% | 80,606 | 4.13B |
| 55 | ILMN | Illumina, Inc. | 34.43B | -4.42% | 1,195,234 | 4.54B |
| 56 | RMD | ResMed Inc. | 33.72B | 5.58% | 795,441 | 5.73B |
| 57 | DXCM | DexCom, Inc. | 32.85B | 6.16% | 1,541,090 | 5.10B |
| 58 | GMAB | Genmab A/S | 32.66B | -1.87% | 2,100,580 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 30.49B | 8.43% | 1,615,093 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.54B | 2.80% | 209,292 | 14.59B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.30B | -0.17% | 331,183 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 27.87B | 2.52% | 225,986 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.69B | 2.52% | 1,999,065 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 25.79B | - | 405,573 | 3.19B |
| 65 | INCY | Incyte Corporation | 24.87B | 3.75% | 775,596 | 6.01B |
| 66 | STE | STERIS plc | 23.97B | 6.27% | 446,836 | 6.04B |
| 67 | INSM | Insmed Incorporated | 23.42B | 2.20% | 596,514 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 23.26B | 9.60% | 860,957 | 22.15B |
| 69 | BNTX | BioNTech SE | 22.79B | 4.38% | 596,126 | 2.75B |
| 70 | GH | Guardant Health, Inc. | 22.66B | -3.49% | 720,402 | 1.18B |
| 71 | VTRS | Viatris Inc. | 21.82B | 0.40% | 2,285,400 | 14.74B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.71B | 1.38% | 1,368,479 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 21.28B | 14.93% | 2,237,000 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.38B | -0.98% | 85,912 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.80B | -2.41% | 1,174,182 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.66B | 0.07% | 1,029,875 | 2.50B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.96B | 1.18% | 964,465 | 3.70B |
| 78 | ASND | Ascendis Pharma A/S | 16.62B | 1.16% | 170,352 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.77B | -6.10% | 698,430 | 3.98B |
| 80 | ICLR | ICON Public Limited Company | 15.39B | 0.83% | 564,103 | 8.23B |
| 81 | SOLV | Solventum Corporation | 15.35B | 6.37% | 423,216 | 8.31B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 15.09B | 1.17% | 239,390 | 4.72B |
| 83 | GKOS | Glaukos Corporation | 14.88B | 7.91% | 646,616 | 690.33M |
| 84 | BBIO | BridgeBio Pharma, Inc. | 14.81B | 2.73% | 2,786,182 | 945.54M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 14.65B | 0.66% | 1,021,763 | 15.25B |
| 86 | HALO | Halozyme Therapeutics, Inc. | 14.59B | -0.03% | 634,795 | 1.66B |
| 87 | BAX | Baxter International Inc. | 13.96B | 5.85% | 2,587,597 | 11.61B |
| 88 | EHC | Encompass Health Corporation | 13.84B | 4.10% | 237,765 | 6.34B |
| 89 | TEM | Tempus AI, Inc. | 13.74B | -3.01% | 3,684,020 | 1.51B |
| 90 | SNN | Smith & Nephew plc | 13.42B | 6.96% | 1,707,627 | 6.30B |
| 91 | PEN | Penumbra, Inc. | 12.72B | 0.87% | 167,368 | 1.56B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.64B | 2.97% | 2,486,428 | 5.02B |
| 93 | SMMT | Summit Therapeutics Inc. | 12.47B | -1.33% | 1,770,601 | - |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.37B | 2.55% | 768,372 | 3.44B |
| 95 | COO | The Cooper Companies, Inc. | 12.29B | 6.28% | 1,224,192 | 4.24B |
| 96 | FMS | Fresenius Medical Care AG | 12.29B | 6.12% | 1,265,839 | 22.12B |
| 97 | DVA | DaVita Inc. | 11.97B | 4.47% | 378,051 | 14.17B |
| 98 | ALGN | Align Technology, Inc. | 11.71B | 8.73% | 593,387 | 4.16B |
| 99 | MOH | Molina Healthcare, Inc. | 11.63B | 7.43% | 817,793 | 42.08B |
| 100 | GMED | Globus Medical, Inc. | 11.63B | 8.82% | 742,647 | 3.14B |
| 101 | UHS | Universal Health Services, Inc. | 11.48B | 10.01% | 500,798 | 18.35B |
| 102 | TECH | Bio-Techne Corporation | 11.41B | 0.18% | 1,524,978 | 1.22B |
| 103 | RGEN | Repligen Corporation | 11.34B | -0.49% | 434,221 | 805.61M |
| 104 | PODD | Insulet Corporation | 11.20B | 4.27% | 917,279 | 3.05B |
| 105 | KYMR | Kymera Therapeutics, Inc. | 11.05B | 1.87% | 551,493 | 102.24M |
| 106 | BMRN | BioMarin Pharmaceutical Inc. | 11.00B | 2.10% | 599,915 | 3.66B |
| 107 | OSCR | Oscar Health, Inc. | 10.96B | 9.69% | 7,218,521 | 15.32B |
| 108 | ENSG | The Ensign Group, Inc. | 10.85B | 2.94% | 136,667 | 5.67B |
| 109 | AVTR | Avantor, Inc. | 10.63B | 0.64% | 3,464,675 | 6.64B |
| 110 | QGEN | Qiagen N.V. | 10.48B | 0.64% | 1,086,557 | 2.10B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 10.13B | 1.08% | 71,980 | 2.59B |
| 112 | HSIC | Henry Schein, Inc. | 9.83B | 6.92% | 642,641 | 13.60B |
| 113 | PCVX | Vaxcyte, Inc. | 9.72B | 1.56% | 604,419 | - |
| 114 | HNGE | Hinge Health, Inc. | 9.68B | 2.68% | 965,740 | 800.82M |
| 115 | BRKR | Bruker Corporation | 9.58B | 11.27% | 4,327,833 | 3.51B |
| 116 | ATR | AptarGroup, Inc. | 9.27B | 2.75% | 118,086 | 3.99B |
| 117 | KRYS | Krystal Biotech, Inc. | 9.18B | 1.52% | 120,008 | 470.03M |
| 118 | CAI | Caris Life Sciences, Inc. | 9.12B | -1.77% | 1,002,153 | 989.61M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.11B | 0.40% | 136,072 | 281.99M |
| 120 | MDGL | Madrigal Pharmaceuticals, Inc. | 8.98B | -1.96% | 1,264,486 | 1.43B |
| 121 | HQY | HealthEquity, Inc. | 8.95B | 6.04% | 507,610 | 1.36B |
| 122 | CYTK | Cytokinetics, Incorporated | 8.94B | 3.15% | 754,950 | 67.67M |
| 123 | SYRE | Spyre Therapeutics, Inc. | 8.93B | -3.73% | 706,168 | - |
| 124 | TGTX | TG Therapeutics, Inc. | 8.88B | 3.00% | 631,410 | 799.54M |
| 125 | IBRX | ImmunityBio, Inc. | 8.84B | 0.60% | 3,329,274 | 165.79M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.65B | 2.92% | 420,709 | 669.50M |
| 127 | TWST | Twist Bioscience Corporation | 8.65B | -1.66% | 684,052 | 431.80M |
| 128 | TXG | 10x Genomics, Inc. | 8.53B | 0.29% | 1,178,781 | 616.91M |
| 129 | CORT | Corcept Therapeutics Incorporated | 8.35B | -5.68% | 1,087,977 | 963.65M |
| 130 | PACS | PACS Group, Inc. | 8.06B | 9.02% | 503,846 | 5.71B |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | 0.43% | 109,732 | 7.46M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.77B | 1.00% | 272,270 | 5.33M |
| 133 | ALKS | Alkermes plc | 7.66B | -0.02% | 547,008 | 1.75B |
| 134 | GRFS | Grifols, S.A. | 7.46B | -1.34% | 318,762 | 8.63B |
| 135 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.42B | 1.23% | 296,408 | 945.96M |
| 136 | BLCO | Bausch + Lomb Corporation | 7.39B | 3.25% | 412,711 | 5.42B |
| 137 | AXSM | Axsome Therapeutics, Inc. | 7.25B | -1.29% | 248,478 | 865.27M |
| 138 | CHE | Chemed Corporation | 7.06B | 2.04% | 41,114 | 2.66B |
| 139 | AMRX | Amneal Pharmaceuticals, Inc. | 6.86B | -2.52% | 1,370,925 | 3.20B |
| 140 | IONS | Ionis Pharmaceuticals, Inc. | 6.63B | -1.24% | 1,190,280 | 874.09M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.60B | 0.30% | 480,306 | 1.56B |
| 142 | ORKA | Oruka Therapeutics, Inc. | 6.52B | -1.13% | 275,793 | - |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.40B | 7.50% | 1,871,214 | 280.75M |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.39B | 6.50% | 7,446,883 | 2.58B |
| 145 | RDNT | RadNet, Inc. | 6.27B | 8.83% | 796,399 | 2.27B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.26B | -0.10% | 53,498 | 253.83M |
| 147 | TFX | Teleflex Incorporated | 6.24B | 5.25% | 370,841 | 2.25B |
| 148 | GRAL | GRAIL, Inc. | 6.21B | -0.22% | 216,115 | 165.26M |
| 149 | KOD | Kodiak Sciences Inc. | 6.17B | -0.46% | 285,007 | - |
| 150 | BLTE | Belite Bio, Inc | 6.15B | 0.42% | 33,009 | - |
| 151 | DOCS | Doximity, Inc. | 6.12B | 5.34% | 1,058,924 | 655.57M |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 6.06B | 7.16% | 365,211 | 670.78M |
| 153 | IMVT | Immunovant, Inc. | 6.05B | 0.88% | 231,974 | - |
| 154 | CGON | CG Oncology, Inc. | 5.79B | 1.89% | 406,650 | 6.23M |
| 155 | PTCT | PTC Therapeutics, Inc. | 5.75B | 1.09% | 404,473 | 1.16B |
| 156 | HAE | Haemonetics Corporation | 5.72B | 4.53% | 245,999 | 1.35B |
| 157 | MMED | MiniMed Group, Inc. | 5.54B | 4.51% | 4,393,808 | 3.22B |
| 158 | MANE | Veradermics, Incorporated | 5.54B | -0.77% | 242,058 | - |
| 159 | WAY | Waystar Holding Corp. | 5.53B | 4.27% | 1,317,652 | 1.26B |
| 160 | SRRK | Scholar Rock Holding Corporation | 5.51B | 2.89% | 392,167 | - |
| 161 | CON | Concentra Group Holdings Parent, Inc. | 5.45B | 6.40% | 969,743 | 2.29B |
| 162 | COGT | Cogent Biosciences, Inc. | 5.39B | 0.06% | 859,521 | - |
| 163 | LIVN | LivaNova PLC | 5.38B | 22.29% | 1,533,215 | 1.51B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.38B | 6.66% | 248,472 | 1.61B |
| 165 | LFST | LifeStance Health Group, Inc. | 5.32B | 4.11% | 858,603 | 1.58B |
| 166 | BLLN | BillionToOne, Inc. | 5.29B | 1.52% | 204,923 | 397.41M |
| 167 | ERAS | Erasca, Inc. | 5.01B | -2.25% | 953,659 | - |
| 168 | CRSP | CRISPR Therapeutics AG | 4.97B | 2.81% | 581,827 | 25.17M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.93B | 5.89% | 1,153,548 | 651.03M |
| 170 | HTFL | HeartFlow, Inc. | 4.88B | 3.16% | 582,060 | 212.07M |
| 171 | OPCH | Option Care Health, Inc. | 4.75B | -0.17% | 1,989,148 | 5.75B |
| 172 | SHC | Sotera Health Company | 4.72B | 3.21% | 1,671,179 | 1.23B |
| 173 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | 1.37% | 326,993 | 1.90M |
| 174 | CDNA | CareDx, Inc. | 4.52B | -2.72% | 598,534 | 497.40M |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.51B | 8.20% | 505,653 | 825.34M |
| 176 | LEGN | Legend Biotech Corporation | 4.37B | 5.07% | 975,381 | 1.27B |
| 177 | LQDA | Liquidia Corporation | 4.34B | 14.93% | 2,970,660 | 450.91M |
| 178 | ICUI | ICU Medical, Inc. | 4.31B | 6.54% | 129,973 | 2.16B |
| 179 | ITGR | Integer Holdings Corporation | 4.31B | 0.13% | 284,749 | 1.83B |
| 180 | NVST | Envista Holdings Corporation | 4.30B | 7.99% | 1,694,162 | 2.86B |
| 181 | DFTX | Definium Therapeutics, Inc. | 4.29B | -4.34% | 593,589 | - |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.20B | 2.00% | 691,331 | 308.08M |
| 183 | VCYT | Veracyte, Inc. | 4.12B | 1.97% | 535,433 | 561.90M |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 4.11B | 0.48% | 240,918 | - |
| 185 | ARQT | Arcutis Biotherapeutics, Inc. | 4.09B | 1.59% | 383,962 | 463.98M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.94B | 5.84% | 120,589 | 1.19M |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.90B | 2.01% | 1,130,491 | 10.35M |
| 188 | ABCL | AbCellera Biologics Inc. | 3.89B | -1.56% | 1,185,837 | 66.17M |
| 189 | TNGX | Tango Therapeutics, Inc. | 3.86B | -1.21% | 614,594 | 53.81M |
| 190 | IOVA | Iovance Biotherapeutics, Inc. | 3.86B | -3.51% | 6,510,075 | 324.97M |
| 191 | XENE | Xenon Pharmaceuticals Inc. | 3.75B | 1.39% | 624,831 | 7.50M |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.70B | 2.32% | 309,186 | 148.00K |
| 193 | IRON | Disc Medicine, Inc. | 3.67B | 1.85% | 112,292 | - |
| 194 | OGN | Organon & Co. | 3.64B | 0.04% | 610,826 | 6.10B |
| 195 | ACAD | Acadia Pharmaceuticals Inc. | 3.64B | 2.63% | 1,624,711 | 1.14B |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.56B | -2.91% | 431,475 | -665.00K |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.48B | 4.52% | 1,635,711 | - |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.46B | 2.55% | 1,449,715 | - |
| 199 | STVN | Stevanato Group S.p.A. | 3.44B | -10.57% | 2,496,017 | 1.42B |
| 200 | DNLI | Denali Therapeutics Inc. | 3.38B | 8.69% | 1,930,325 | 21.38M |
| 201 | CELC | Celcuity Inc. | 3.37B | -1.22% | 406,146 | - |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.33B | 5.54% | 146,251 | 890.79M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.33B | 1.23% | 299,160 | - |
| 204 | SUPN | Supernus Pharmaceuticals, Inc. | 3.32B | -0.18% | 1,995,611 | 1.37B |
| 205 | ATRC | AtriCure, Inc. | 3.29B | 7.12% | 469,481 | 589.80M |
| 206 | NHC | National HealthCare Corporation | 3.29B | 1.98% | 86,655 | 1.56B |
| 207 | BHC | Bausch Health Companies Inc. | 3.14B | 3.19% | 1,342,836 | 11.11B |
| 208 | VRDN | Viridian Therapeutics, Inc. | 3.14B | 10.22% | 5,816,036 | 26.31M |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 3.13B | 13.44% | 1,560,049 | 3.37B |
| 210 | AXGN | Axogen, Inc. | 3.13B | 5.80% | 676,906 | 266.93M |
| 211 | AVAH | Aveanna Healthcare Holdings Inc. | 3.09B | 6.78% | 695,734 | 2.60B |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | 1.05% | 382,605 | 36.54M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.03B | -5.04% | 1,126,216 | 682.20M |
| 214 | SGRY | Surgery Partners, Inc. | 3.01B | 0.45% | 2,504,759 | 3.37B |
| 215 | PRVA | Privia Health Group, Inc. | 2.85B | 4.01% | 710,473 | 2.36B |
| 216 | WRBY | Warby Parker Inc. | 2.84B | 4.69% | 2,982,911 | 911.61M |
| 217 | ZLAB | Zai Lab Limited | 2.83B | 3.87% | 345,271 | 449.61M |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.82B | -7.40% | 119,904 | - |
| 219 | NEOG | Neogen Corporation | 2.73B | 3.47% | 1,588,842 | 884.00M |
| 220 | RCUS | Arcus Biosciences, Inc. | 2.73B | 0.37% | 432,058 | 117.00M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.72B | 3.34% | 454,350 | 146.64M |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.71B | 4.84% | 283,325 | 1.46B |
| 223 | BKD | Brookdale Senior Living Inc. | 2.64B | 6.80% | 1,752,671 | 2.93B |
| 224 | TMDX | TransMedics Group, Inc. | 2.57B | 10.26% | 592,733 | 668.47M |
| 225 | UFPT | UFP Technologies, Inc. | 2.56B | 17.83% | 186,693 | 649.52M |
| 226 | MBX | MBX Biosciences, Inc. | 2.54B | -4.16% | 124,885 | - |
| 227 | MD | Pediatrix Medical Group, Inc. | 2.52B | 8.04% | 319,527 | 1.96B |
| 228 | ADMA | ADMA Biologics, Inc. | 2.52B | 1.13% | 2,752,454 | 512.28M |
| 229 | HCM | HUTCHMED (China) Limited | 2.52B | 5.73% | 71,163 | 549.12M |
| 230 | CLOV | Clover Health Investments, Corp. | 2.49B | 9.32% | 2,935,463 | 2.48B |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | 6.10% | 169,189 | 1.10B |
| 232 | XNCR | Xencor, Inc. | 2.46B | 7.80% | 607,235 | 104.97M |
| 233 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 3.17% | 577,230 | 7.12M |
| 234 | PHVS | Pharvaris N.V. | 2.42B | -0.95% | 144,633 | - |
| 235 | PGNY | Progyny, Inc. | 2.36B | 5.64% | 276,585 | 1.31B |
| 236 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | 5.43% | 10,153,230 | 68.23M |
| 237 | ADUS | Addus HomeCare Corporation | 2.31B | -0.23% | 161,702 | 1.50B |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.31B | -1.14% | 154,831 | 158.00K |
| 239 | BHVN | Biohaven Ltd. | 2.29B | -2.88% | 445,382 | - |
| 240 | VCEL | Vericel Corporation | 2.29B | 8.66% | 421,971 | 306.30M |
| 241 | PRGO | Perrigo Company plc | 2.29B | 4.90% | 2,331,914 | 4.09B |
| 242 | VERA | Vera Therapeutics, Inc. | 2.28B | 2.96% | 855,883 | - |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | 2.05% | 515,814 | 321.74M |
| 244 | SEPN | Septerna, Inc. | 2.24B | 9.63% | 205,310 | 98.88M |
| 245 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 1.11% | 76,921 | - |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.20B | 0.64% | 1,784,632 | 961.51M |
| 247 | IMNM | Immunome, Inc. | 2.19B | -8.47% | 1,385,188 | 4.02M |
| 248 | NEO | NeoGenomics, Inc. | 2.19B | 0.65% | 317,249 | 787.75M |
| 249 | ZYME | Zymeworks Inc. | 2.19B | 2.46% | 365,190 | 37.13M |
| 250 | TRLV | Trulieve Cannabis Corp. | 2.18B | -1.91% | 1,215,535 | 1.14B |
| 251 | LKFT | Lakefront Biotherapeutics NV | 2.15B | 4.39% | 190,903 | 1.13B |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.13B | 9.61% | 2,798,520 | 3.64B |
| 253 | WGS | GeneDx Holdings Corp. | 2.06B | 0.46% | 196,584 | 454.43M |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.05B | 1.93% | 141,100 | - |
| 255 | SDGR | Schrödinger, Inc. | 2.03B | 0.04% | 430,287 | 259.04M |
| 256 | ASTH | Astrana Health, Inc. | 2.03B | 7.95% | 140,711 | 3.84B |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | 2.80% | 382,684 | 1.97B |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 2.01B | 3.34% | 290,178 | - |
| 259 | LMAT | LeMaitre Vascular, Inc. | 2.00B | 8.56% | 136,449 | 262.43M |
| 260 | REPL | Replimune Group, Inc. | 1.98B | 1.31% | 1,199,547 | - |
| 261 | FTRE | Fortrea Holdings Inc. | 1.98B | -1.91% | 361,032 | 2.67B |
| 262 | ESTA | Establishment Labs Holdings Inc. | 1.97B | 7.92% | 159,508 | 264.03M |
| 263 | TRVI | Trevi Therapeutics, Inc. | 1.96B | -0.94% | 399,457 | - |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -9.29% | 1,143,357 | 989.36M |
| 265 | INSP | Inspire Medical Systems, Inc. | 1.94B | 8.68% | 254,726 | 880.94M |
| 266 | VIR | Vir Biotechnology, Inc. | 1.94B | 2.41% | 789,051 | 303.23M |
| 267 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | 0.34% | 769,935 | 208.78M |
| 268 | XERS | Xeris Biopharma Holdings, Inc. | 1.94B | 2.71% | 726,313 | 335.41M |
| 269 | KMTS | Kestra Medical Technologies, Ltd. | 1.87B | 8.41% | 522,319 | 106.73M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | -0.48% | 188,164 | 98.34M |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.84B | -0.28% | 176,508 | 1.00M |
| 272 | MESO | Mesoblast Limited | 1.84B | -3.18% | 124,875 | 120.25M |
| 273 | ARDT | Ardent Health, Inc. | 1.83B | 11.02% | 365,078 | 6.41B |
| 274 | ALMR | Alamar Biosciences, Inc. | 1.82B | -13.14% | 609,802 | 114.05M |
| 275 | BFLY | Butterfly Network, Inc. | 1.82B | 6.41% | 3,032,255 | 123.26M |
| 276 | AMN | AMN Healthcare Services, Inc. | 1.81B | 2.94% | 161,240 | 3.43B |
| 277 | HCSG | Healthcare Services Group, Inc. | 1.80B | 4.54% | 191,911 | 1.88B |
| 278 | SLS | SELLAS Life Sciences Group, Inc. | 1.80B | 0.45% | 2,635,758 | - |
| 279 | MAZE | Maze Therapeutics, Inc. | 1.78B | 2.26% | 147,275 | 20.00M |
| 280 | GENB | Generate Biomedicines, Inc. | 1.78B | - | 232,715 | 26.48M |
| 281 | OMCL | Omnicell, Inc. | 1.76B | 8.97% | 324,801 | 1.24B |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.76B | 0.59% | 308,725 | 28.21M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.74B | 7.83% | 191,926 | 481.07M |
| 284 | PGEN | Precigen, Inc. | 1.73B | -7.81% | 4,219,558 | 85.72M |
| 285 | ADRX | ADARx Pharmaceuticals, Inc. | 1.73B | -3.92% | 159,788 | 6.13M |
| 286 | TDOC | Teladoc Health, Inc. | 1.73B | 6.52% | 3,163,367 | 2.47B |
| 287 | RARE | Ultragenyx Pharmaceutical Inc. | 1.72B | 5.41% | 2,504,422 | 730.00M |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 3.12% | 1,071,696 | 59.51M |
| 289 | ABSI | Absci Corporation | 1.71B | -0.30% | 2,043,658 | 1.56M |
| 290 | NVAX | Novavax, Inc. | 1.69B | 6.04% | 2,601,581 | 413.80M |
| 291 | AZTA | Azenta, Inc. | 1.69B | 3.93% | 250,975 | 613.81M |
| 292 | NVCR | NovoCure Limited | 1.69B | 7.63% | 399,243 | 725.39M |
| 293 | PSNL | Personalis, Inc. | 1.68B | 0.06% | 1,209,405 | 69.67M |
| 294 | CERT | Certara, Inc. | 1.67B | 0.78% | 829,878 | 421.75M |
| 295 | NRIX | Nurix Therapeutics, Inc. | 1.66B | -41.13% | 10,820,887 | 701.94M |
| 296 | KLRA | Kailera Therapeutics, Inc. | 1.63B | -0.20% | 166,815 | - |
| 297 | BRVE | Braveheart Bio, Inc. | 1.62B | -6.95% | 109,229 | - |
| 298 | ALVO | Alvotech | 1.62B | -0.22% | 149,354 | 494.61M |
| 299 | ALHC | Alignment Healthcare, Inc. | 1.61B | 4.26% | 1,932,445 | 4.94B |
| 300 | NUVB | Nuvation Bio Inc. | 1.61B | -2.24% | 3,446,755 | 169.90M |
| 301 | AGL | agilon health, inc. | 1.60B | 8.73% | 116,973 | 5.92B |
| 302 | PAHC | Phibro Animal Health Corporation | 1.60B | 4.83% | 56,216 | 1.52B |
| 303 | LYCA | Lycia Therapeutics, Inc. | 1.57B | -1.67% | 66,688 | 4.44M |
| 304 | CNMD | CONMED Corporation | 1.56B | 11.07% | 152,548 | 1.37B |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.59% | 70,632 | 978.38M |
| 306 | OCUL | Ocular Therapeutix, Inc. | 1.55B | 3.81% | 1,797,223 | 52.06M |
| 307 | QURE | uniQure N.V. | 1.54B | -6.74% | 1,169,261 | 18.67M |
| 308 | INVA | Innoviva, Inc. | 1.54B | 2.01% | 188,605 | 440.00M |
| 309 | NBTX | Nanobiotix S.A. | 1.53B | 5.04% | 51,588 | 13.15M |
| 310 | PNTG | The Pennant Group, Inc. | 1.53B | 6.00% | 79,593 | 1.10B |
| 311 | RAPP | Rapport Therapeutics, Inc. | 1.52B | 0.98% | 339,869 | 20.00M |
| 312 | IMCR | Immunocore Holdings plc | 1.49B | -3.70% | 155,749 | 430.78M |
| 313 | URGN | UroGen Pharma Ltd. | 1.46B | -13.02% | 1,452,286 | 250.25M |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.46B | -0.56% | 241,456 | - |
| 315 | AAPG | Ascentage Pharma Group International | 1.46B | 9.79% | 11,528 | 94.61M |
| 316 | ETON | Eton Pharmaceuticals, Inc. | 1.45B | -0.20% | 102,727 | 105.60M |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.11% | 1,558,325 | 746.16M |
| 318 | MLYS | Mineralys Therapeutics, Inc. | 1.45B | 2.38% | 535,090 | - |
| 319 | GPCR | Structure Therapeutics Inc. | 1.45B | -0.29% | 265,314 | - |
| 320 | KRSA | Korsana Biosciences, Inc. | 1.42B | -2.69% | 44,704 | - |
| 321 | KARD | Kardigan, Inc. | 1.41B | 5.45% | 132,880 | - |
| 322 | ANAB | AnaptysBio, Inc. | 1.41B | -1.13% | 177,809 | 106.09M |
| 323 | ENOV | Enovis Corporation | 1.41B | 16.75% | 1,642,505 | 2.30B |
| 324 | NUTX | Nutex Health Inc. | 1.38B | 11.88% | 81,804 | 846.72M |
| 325 | STAA | STAAR Surgical Company | 1.36B | 8.07% | 363,340 | 339.59M |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.36B | -0.27% | 157,042 | - |
| 327 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | 1.22% | 897,042 | 5.49M |
| 328 | OPK | OPKO Health, Inc. | 1.34B | 4.36% | 1,140,358 | 587.90M |
| 329 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 8.61% | 932,020 | 1.04B |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.33B | 5.38% | 71,265 | 804.27M |
| 331 | PRCT | PROCEPT BioRobotics Corporation | 1.33B | 14.87% | 665,992 | 337.34M |
| 332 | INNV | InnovAge Holding Corp. | 1.32B | 9.04% | 284,296 | 1.02B |
| 333 | OMER | Omeros Corporation | 1.31B | -0.71% | 331,552 | 38.42M |
| 334 | NKTR | Nektar Therapeutics | 1.30B | 1.07% | 149,776 | 54.59M |
| 335 | CRON | Cronos Group Inc. | 1.30B | 3.85% | 1,110,191 | 179.09M |
| 336 | GHRS | GH Research PLC | 1.29B | -7.59% | 110,463 | - |
| 337 | LBRX | LB Pharmaceuticals Inc | 1.28B | -1.90% | 145,529 | - |
| 338 | DRTS | Alpha Tau Medical Ltd. | 1.27B | 1.81% | 223,542 | - |
| 339 | MNKD | MannKind Corporation | 1.26B | 5.09% | 1,498,785 | 393.63M |
| 340 | GDRX | GoodRx Holdings, Inc. | 1.26B | 5.73% | 760,717 | 785.23M |
| 341 | AORT | Artivion, Inc. | 1.25B | 7.84% | 232,294 | 471.47M |
| 342 | ATEC | Alphatec Holdings, Inc. | 1.24B | 7.10% | 2,742,020 | 839.72M |
| 343 | LMRI | Lumexa Imaging Holdings, Inc. | 1.24B | 14.62% | 555,174 | 1.04B |
| 344 | VOR | Vor Biopharma Inc. | 1.22B | 0.33% | 156,102 | - |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 2.29% | 90,364 | 1.30M |
| 346 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.20B | 4.42% | 224,394 | 730.02M |
| 347 | SLN | Silence Therapeutics plc | 1.19B | 0.03% | 634,505 | 615.00K |
| 348 | OMDA | Omada Health, Inc. | 1.19B | 4.47% | 320,576 | 309.76M |
| 349 | AVLN | Avalyn Pharma Inc. | 1.18B | -0.34% | 71,291 | - |
| 350 | FRNM | Freenome, Inc. | 1.18B | -4.45% | 182,063 | 35.41M |
| 351 | SGP | SpyGlass Pharma, Inc. | 1.17B | 1.57% | 35,701 | - |
| 352 | VSTM | Verastem, Inc. | 1.17B | -1.54% | 997,590 | 87.53M |
| 353 | SVRA | Savara Inc. | 1.17B | -3.47% | 1,539,997 | - |
| 354 | CMPS | COMPASS Pathways plc | 1.16B | -2.10% | 2,722,348 | - |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.15B | 8.44% | 390,726 | 1.66B |
| 356 | IRMD | IRADIMED CORPORATION | 1.12B | 7.92% | 59,741 | 89.34M |
| 357 | SIBN | SI-BONE, Inc. | 1.11B | 4.12% | 1,139,628 | 220.65M |
| 358 | CSTL | Castle Biosciences, Inc. | 1.10B | 2.02% | 68,088 | 357.28M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 0.69% | 94,607 | - |
| 360 | HROW | Harrow, Inc. | 1.08B | 1.33% | 247,679 | 275.59M |
| 361 | JANX | Janux Therapeutics, Inc. | 1.07B | -1.46% | 139,784 | 24.00M |
| 362 | CBLL | CeriBell, Inc. | 1.07B | -1.45% | 623,371 | 108.72M |
| 363 | AHG | Akso Health Group | 1.04B | 0.33% | 129 | 13.83M |
| 364 | HSTM | HealthStream, Inc. | 996.81M | 2.87% | 79,934 | 327.95M |
| 365 | ODTX | Odyssey Therapeutics, Inc. | 990.47M | -4.17% | 306,017 | 99.00K |
| 366 | BVS | Bioventus Inc. | 989.76M | 7.54% | 413,572 | 585.64M |
| 367 | QDEL | QuidelOrtho Corporation | 987.49M | 2.20% | 1,208,135 | 2.59B |
| 368 | GMRS | GMR Solutions Inc. | 967.64M | 9.31% | 275,646 | 5.88B |
| 369 | AHCO | AdaptHealth Corp. | 964.55M | 15.13% | 2,511,186 | 3.44B |
| 370 | LTGO | Latigo Biotherapeutics, Inc. | 962.00M | -0.41% | 63,345 | - |
| 371 | RIGL | Rigel Pharmaceuticals, Inc. | 958.65M | 5.03% | 65,980 | 276.79M |
| 372 | MLTX | MoonLake Immunotherapeutics | 957.45M | -3.85% | 508,655 | - |
| 373 | IMTX | Immatics N.V. | 951.36M | -1.63% | 182,538 | 47.65M |
| 374 | SNDX | Syndax Pharmaceuticals, Inc. | 944.76M | -25.96% | 7,175,176 | 289.68M |
| 375 | ORIC | ORIC Pharmaceuticals, Inc. | 941.17M | -5.32% | 1,745,089 | - |
| 376 | JBIO | Jade Biosciences, Inc. | 932.34M | 0.62% | 371,616 | - |
| 377 | IVA | Inventiva S.A. | 927.23M | -1.24% | 960,154 | 2.81M |
| 378 | MGTX | MeiraGTx Holdings plc | 922.97M | 0.95% | 167,581 | 397.50M |
| 379 | CTY | City Therapeutics, Inc. | 906.07M | -4.61% | 166,120 | 14.34M |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 893.23M | 0.58% | 339,075 | 28.73M |
| 381 | BBNX | Beta Bionics, Inc. | 888.63M | 8.25% | 309,405 | 127.27M |
| 382 | ANRO | Alto Neuroscience, Inc. | 887.26M | -0.40% | 133,920 | - |
| 383 | PRME | Prime Medicine, Inc. | 883.29M | 9.12% | 2,009,790 | 4.07M |
| 384 | PHAR | Pharming Group N.V. | 882.02M | -1.78% | 24,280 | 386.75M |
| 385 | KIDS | OrthoPediatrics Corp. | 878.88M | 7.16% | 208,244 | 264.14M |
| 386 | CGEM | Cullinan Therapeutics, Inc. | 861.71M | -14.98% | 385,663 | - |
| 387 | CRVS | Corvus Pharmaceuticals, Inc. | 856.35M | 3.56% | 536,644 | - |
| 388 | AKTS | Aktis Oncology, Inc. | 832.35M | 0.17% | 85,703 | 10.06M |
| 389 | ALMS | Alumis Inc. | 831.62M | -1.15% | 421,187 | 7.40M |
| 390 | INMD | InMode Ltd. | 823.12M | 1.70% | 318,505 | 374.63M |
| 391 | ANNX | Annexon, Inc. | 814.24M | 2.51% | 1,722,076 | - |
| 392 | BBTX | Bambusa Therapeutics, Inc. | 806.93M | -1.00% | 99,574 | - |
| 393 | PHR | Phreesia, Inc. | 804.75M | 6.01% | 154,530 | 507.79M |
| 394 | PACB | Pacific Biosciences of California, Inc. | 792.62M | 4.51% | 9,221,138 | 159.27M |
| 395 | ARDX | Ardelyx, Inc. | 792.42M | 4.95% | 4,138,302 | 468.22M |
| 396 | ABUS | Arbutus Biopharma Corporation | 783.48M | 2.06% | 610,450 | 181.72M |
| 397 | COLL | Collegium Pharmaceutical, Inc. | 783.29M | 1.39% | 192,520 | 808.21M |
| 398 | VREX | Varex Imaging Corporation | 781.00M | - | 157,244 | 865.00M |
| 399 | CTKB | Cytek Biosciences, Inc. | 779.90M | 0.67% | 550,586 | 206.71M |
| 400 | SANA | Sana Biotechnology, Inc. | 763.37M | 4.51% | 1,116,127 | - |
| 401 | DNA | Ginkgo Bioworks Holdings, Inc. | 757.58M | 4.55% | 987,204 | 132.42M |
| 402 | OABI | OmniAb, Inc. | 741.70M | -1.26% | 462,051 | 40.21M |
| 403 | OBX | Obsidian Therapeutics, Inc. | 736.95M | -9.83% | 172,764 | - |
| 404 | KURA | Kura Oncology, Inc. | 735.70M | -16.30% | 3,103,469 | 77.23M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 718.26M | 3.71% | 366,672 | - |
| 406 | WVE | Wave Life Sciences, Inc. | 712.00M | 0.84% | 1,011,099 | 70.92M |
| 407 | STLN | Starling Oncology, Inc. | 700.16M | 8.36% | 581,716 | 587.24M |
| 408 | SGMT | Sagimet Biosciences Inc. | 694.90M | -1.51% | 344,533 | - |
| 409 | SLBT | SL Science Holding Limited | 684.32M | -1.64% | 14,406 | 3.27M |
| 410 | SLDB | Solid Biosciences Inc. | 684.10M | 1.59% | 455,696 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 670.30M | -0.68% | 383,220 | - |
| 412 | ATTO | Attovia Therapeutics, Inc. | 667.42M | -4.26% | 78,261 | 1.80M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 662.93M | 0.42% | 319,907 | 92.01M |
| 414 | AURA | Aura Biosciences, Inc. | 658.53M | 1.76% | 238,639 | - |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 656.31M | 1.03% | 480,599 | 41.47M |
| 416 | ZVRA | Zevra Therapeutics, Inc. | 654.41M | 7.41% | 810,043 | 147.76M |
| 417 | DSGN | Design Therapeutics, Inc. | 653.35M | 0.97% | 101,808 | - |
| 418 | TCMD | Tactile Systems Technology, Inc. | 646.38M | 15.15% | 276,970 | 356.42M |
| 419 | IAM | Iambic Therapeutics, Inc. | 642.75M | 0.52% | 174,053 | 18.25M |
| 420 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | -0.27% | 480,352 | - |
| 421 | HELP | Helus Pharma Inc. | 638.91M | -3.16% | 343,690 | - |
| 422 | IMMX | Immix Biopharma, Inc. | 638.35M | -0.13% | 431,736 | - |
| 423 | GERN | Geron Corporation | 638.17M | 6.81% | 15,356,211 | 217.52M |
| 424 | AVBP | ArriVent BioPharma, Inc. | 631.14M | -1.69% | 336,794 | - |
| 425 | APMD | Apnimed, Inc. | 620.30M | -1.06% | 129,653 | 115.12M |
| 426 | DBVT | DBV Technologies S.A. | 619.46M | -1.43% | 96,062 | 3.74M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 610.56M | 5.57% | 584,795 | 389.32M |
| 428 | ANL | Adlai Nortye Group Ltd. | 608.56M | -1.36% | 49,979 | 18.06M |
| 429 | DMAC | DiaMedica Therapeutics Inc. | 581.32M | 7.80% | 201,634 | - |
| 430 | EVO | Evotec SE | 580.00M | 1.93% | 20,837 | 819.47M |
| 431 | CBIO | Crescent Biopharma, Inc. | 579.53M | 3.68% | 43,911 | 11.88M |
| 432 | SOPH | SOPHiA GENETICS SA | 578.87M | -1.59% | 246,838 | 90.97M |
| 433 | BCAX | Bicara Therapeutics Inc. | 578.35M | -2.46% | 309,230 | - |
| 434 | MYGN | Myriad Genetics, Inc. | 577.72M | - | 582,230 | 806.60M |
| 435 | AVR | Anteris Technologies Global Corp. | 574.24M | 5.18% | 397,469 | 2.24M |
| 436 | ACRS | Aclaris Therapeutics, Inc. | 571.89M | -1.34% | 560,171 | 8.22M |
| 437 | NVCT | Nuvectis Pharma, Inc. | 568.55M | -9.77% | 77,859 | - |
| 438 | EVH | Evolent Health, Inc. | 554.56M | 14.07% | 686,064 | 2.10B |
| 439 | PBYI | Puma Biotechnology, Inc. | 553.88M | 4.99% | 111,522 | 231.24M |
| 440 | SGHT | Sight Sciences, Inc. | 552.53M | 6.48% | 334,056 | 83.38M |
| 441 | VALN | Valneva SE | 551.28M | 4.72% | 5,390 | 163.30M |
| 442 | ENTX | Entera Bio Ltd. | 546.12M | 2.95% | 71,187 | 42.00K |
| 443 | SRZN | Surrozen, Inc. | 540.08M | 2.49% | 71,745 | 11.51M |
| 444 | FLGT | Fulgent Genetics, Inc. | 538.75M | 1.08% | 86,379 | 323.93M |
| 445 | NRC | NRC Health | 538.60M | 5.44% | 88,764 | 143.79M |
| 446 | CLYM | Climb Bio, Inc. | 538.46M | -3.85% | 215,197 | - |
| 447 | NGNE | Neurogene Inc. | 533.80M | 0.02% | 47,743 | 925.00K |
| 448 | STTK | Shattuck Labs, Inc. | 530.92M | -3.29% | 214,378 | 1.00M |
| 449 | ANGO | AngioDynamics, Inc. | 520.63M | 5.54% | 236,664 | 325.38M |
| 450 | RGNX | REGENXBIO Inc. | 518.20M | 2.88% | 330,016 | 174.48M |
| 451 | INDP | Indaptus Therapeutics, Inc. | 514.50M | 3.40% | 45,990 | - |
| 452 | DCTH | Delcath Systems, Inc. | 511.46M | 2.36% | 117,423 | 95.42M |
| 453 | FTH | Faeth Therapeutics, Inc. | 507.89M | 0.03% | 135,749 | - |
| 454 | RCEL | AVITA Medical, Inc. | 506.58M | 6.85% | 242,628 | 75.63M |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 456 | EOLS | Evolus, Inc. | 499.34M | 2.58% | 197,137 | 316.49M |
| 457 | AQST | Aquestive Therapeutics, Inc. | 498.28M | 2.32% | 1,402,024 | 48.84M |
| 458 | CERS | Cerus Corporation | 493.74M | 4.70% | 848,741 | 226.57M |
| 459 | CTMX | CytomX Therapeutics, Inc. | 493.54M | 3.90% | 2,133,653 | 18.30M |
| 460 | SENS | Senseonics Holdings, Inc. | 493.05M | 5.25% | 257,530 | 48.55M |
| 461 | CAPR | Capricor Therapeutics, Inc. | 492.44M | 2.79% | 2,976,968 | 11.13M |
| 462 | ARVN | Arvinas, Inc. | 477.97M | 3.10% | 361,004 | 275.30M |
| 463 | OVID | Ovid Therapeutics Inc. | 476.53M | 1.67% | 597,358 | 1.58M |
| 464 | MNPR | Monopar Therapeutics Inc. | 475.89M | 1.45% | 136,185 | - |
| 465 | NPCE | NeuroPace, Inc. | 473.67M | 12.10% | 46,120 | 106.99M |
| 466 | MDXG | MiMedx Group, Inc. | 471.34M | -0.62% | 406,802 | 303.73M |
| 467 | SSII | SS Innovations International, Inc. | 464.89M | -0.43% | 16,130 | 52.40M |
| 468 | GYRE | Gyre Therapeutics, Inc. | 463.37M | -1.58% | 180,758 | 109.82M |
| 469 | PHAT | Phathom Pharmaceuticals, Inc. | 455.13M | -0.17% | 477,768 | 274.88M |
| 470 | RLMD | Relmada Therapeutics, Inc. | 454.95M | -0.12% | 1,121,980 | - |
| 471 | MASS | 908 Devices Inc. | 454.46M | 3.05% | 100,670 | 60.84M |
| 472 | YDES | YD Bio Limited | 453.32M | 0.08% | 23,943 | 1.24M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.42M | -0.44% | 32,490 | - |
| 474 | SRTA | Strata Critical Medical, Inc. | 449.41M | 14.41% | 1,453,174 | 280.76M |
| 475 | BWAY | BrainsWay Ltd. | 449.38M | 0.35% | 34,367 | 60.70M |
| 476 | ETRA | Electra Therapeutics, Inc. | 443.13M | -12.52% | 138,347 | - |
| 477 | TKNO | Alpha Teknova, Inc. | 441.17M | -2.59% | 107,602 | 43.70M |
| 478 | CRMD | CorMedix Inc. | 441.16M | 1.80% | 622,589 | 462.25M |
| 479 | SI | Shoulder Innovations, Inc. | 441.15M | 6.91% | 35,014 | 60.06M |
| 480 | OCS | Oculis Holding AG | 439.53M | -6.68% | 261,706 | 1.12M |
| 481 | CARL | Carlsmed, Inc. | 438.48M | 11.53% | 44,656 | 63.30M |
| 482 | PRTA | Prothena Corporation plc | 431.74M | 2.44% | 84,965 | 54.53M |
| 483 | TLRY | Tilray Brands, Inc. | 429.72M | 10.57% | 5,892,363 | 963.10M |
| 484 | RZLT | Rezolute, Inc. | 425.88M | 1.25% | 437,068 | - |
| 485 | PRLD | Prelude Therapeutics Incorporated | 422.28M | 8.47% | 202,872 | 22.42M |
| 486 | KMDA | Kamada Ltd. | 414.90M | 2.34% | 64,969 | 191.85M |
| 487 | EDIT | Editas Medicine, Inc. | 411.59M | 3.08% | 1,062,387 | 47.01M |
| 488 | ASMB | Assembly Biosciences, Inc. | 406.09M | 0.13% | 50,926 | 74.85M |
| 489 | ALT | Altimmune, Inc. | 404.60M | 1.96% | 1,118,757 | 31.00K |
| 490 | ALLO | Allogene Therapeutics, Inc. | 400.77M | 3.57% | 6,472,504 | 4.64M |
| 491 | OFIX | Orthofix Medical Inc. | 398.36M | 11.64% | 510,847 | 833.19M |
| 492 | VMD | Viemed Healthcare, Inc. | 384.31M | 6.72% | 65,463 | 301.61M |
| 493 | ZURA | Zura Bio Limited | 382.89M | -0.38% | 989,074 | - |
| 494 | TECX | Tectonic Therapeutic, Inc. | 382.87M | 3.19% | 91,088 | - |
| 495 | EMBC | Embecta Corp. | 382.74M | 11.10% | 482,470 | 1.02B |
| 496 | LYEL | Lyell Immunopharma, Inc. | 377.87M | 43.18% | 597,444 | 27.00K |
| 497 | CCCC | C4 Therapeutics, Inc. | 377.07M | -4.52% | 832,977 | 35.04M |
| 498 | MOBI | Mobia Medical, Inc. | 374.19M | 12.74% | 101,106 | 45.28M |
| 499 | AVTX | Avalo Therapeutics, Inc. | 373.80M | -3.86% | 437,704 | 59.00K |
| 500 | FENC | Fennec Pharmaceuticals Inc. | 372.76M | -0.65% | 42,778 | 59.22M |